Rogaratinib
≥99%
- Product Code: 102373
CAS:
1443530-05-9
| Molecular Weight: | 466.56 g./mol | Molecular Formula: | C₂₃H₂₆N₆O₃S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Rogaratinib is primarily investigated for its potential in treating cancers, particularly those driven by fibroblast growth factor receptor (FGFR) alterations. It is being studied in clinical trials for its efficacy in targeting FGFR1-4, which are often overexpressed or mutated in various cancers, including bladder, lung, and breast cancers. By inhibiting these receptors, Rogaratinib aims to disrupt cancer cell growth and survival. Its application is especially promising in patients with FGFR-positive tumors, offering a targeted therapy approach that could improve outcomes compared to traditional treatments. Research is ongoing to determine its full therapeutic potential and safety profile.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Powder |
| Purity (%) | 98.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | €395.73 |
+
-
|
| 0.005 | 10-20 days | €1,424.63 |
+
-
|
Rogaratinib
Rogaratinib is primarily investigated for its potential in treating cancers, particularly those driven by fibroblast growth factor receptor (FGFR) alterations. It is being studied in clinical trials for its efficacy in targeting FGFR1-4, which are often overexpressed or mutated in various cancers, including bladder, lung, and breast cancers. By inhibiting these receptors, Rogaratinib aims to disrupt cancer cell growth and survival. Its application is especially promising in patients with FGFR-positive tumors, offering a targeted therapy approach that could improve outcomes compared to traditional treatments. Research is ongoing to determine its full therapeutic potential and safety profile.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :